|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
DE68907045T2
(de)
|
1989-01-17 |
1993-12-02 |
Eniricerche Spa |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
*
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
JP2002539273A
(ja)
|
1999-03-19 |
2002-11-19 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
CA2365914A1
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
JP2003535024A
(ja)
|
1999-06-29 |
2003-11-25 |
エピミューン インコーポレイテッド |
Ｈｌａ結合ペプチドおよびそれらの使用
|
|
AU2087401A
(en)
*
|
1999-12-10 |
2001-06-18 |
Epimmune, Inc. |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
|
|
EP1257289A1
(en)
|
2000-02-08 |
2002-11-20 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
CA2400215A1
(en)
*
|
2000-02-23 |
2001-08-30 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
EP1496923A4
(en)
|
2002-03-22 |
2005-10-19 |
Penn State Res Found |
IMMUNOTHERAPY AGAINST CANCER
|
|
US20060079453A1
(en)
|
2002-10-03 |
2006-04-13 |
John Sidney |
Hla binding peptides and their uses
|
|
CN1954217B
(zh)
*
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
US7612162B2
(en)
|
2004-09-21 |
2009-11-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
|
US20120052080A1
(en)
|
2004-09-21 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
WO2008073463A2
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
JP2010190572A
(ja)
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
KR101586617B1
(ko)
|
2007-06-18 |
2016-01-20 |
머크 샤프 앤 도메 비.브이. |
사람 프로그램된 사멸 수용체 ｐｄ-1에 대한 항체
|
|
MX2010002002A
(es)
|
2007-08-20 |
2010-03-11 |
Oncotherapy Science Inc |
Peptido foxm1 y agente medicinal que lo contiene.
|
|
EP2324057B1
(en)
*
|
2008-08-12 |
2018-03-21 |
MSD Italia S.r.l. |
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
|
|
EP4209510B1
(en)
|
2008-12-09 |
2024-01-31 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2010129033A2
(en)
*
|
2009-04-29 |
2010-11-11 |
Calmune Corporation |
Modified antibodies for passive immunotherapy
|
|
NO2504364T3
(enExample)
|
2009-11-24 |
2018-01-06 |
|
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
EP3855184B1
(en)
|
2012-03-19 |
2023-12-27 |
Stemline Therapeutics Inc. |
Methods for treating and monitoring the status of cancer
|
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
RS62406B1
(sr)
|
2012-05-16 |
2021-10-29 |
Stemline Therapeutics Inc |
Vakcine protiv kancera sa ciljanim delovanjem na matične ćelije kancera
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
CA2893359C
(en)
|
2012-12-05 |
2021-12-28 |
Strategia Therapeutics, Inc. |
Protein expression enhancing polypeptides
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
JP7013240B2
(ja)
|
2015-02-16 |
2022-01-31 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｈｅｒ２／Ｎｅｕ （ＥＲＢＢ２）受容体タンパク質に由来する３６９～３７７位エピトープに特異的な完全ヒトＴ細胞受容体
|
|
WO2016146143A1
(en)
|
2015-03-16 |
2016-09-22 |
Amal Therapeutics Sa |
Cell penetrating peptides and complexes comprising the same
|
|
CN108026513A
(zh)
*
|
2015-03-31 |
2018-05-11 |
新加坡科技研究局 |
树突状细胞的抗原加载的方法和疫苗
|
|
EP3464630A1
(en)
|
2016-05-23 |
2019-04-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
CN110049774A
(zh)
|
2016-10-07 |
2019-07-23 |
恩特罗姆公司 |
肿瘤相关抗原表位的小型生物群序列变体
|
|
IL302345B2
(en)
|
2016-10-07 |
2024-12-01 |
Enterome S A |
Immunogenic compounds for cancer therapy
|
|
CN110022894B
(zh)
|
2016-10-07 |
2024-01-19 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
JP7232825B2
(ja)
|
2017-10-09 |
2023-03-03 |
エンテローム エスエー |
腫瘍関連抗原エピトープの微生物叢（ｍｉｃｒｏｂｉｏｔａ）配列変異体
|
|
WO2019197563A2
(en)
|
2018-04-11 |
2019-10-17 |
Enterome S.A. |
Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation
|
|
DK3773689T5
(da)
|
2018-04-11 |
2024-08-19 |
Enterome S A |
Antigene peptider til forebyggelse og behandling af kræft
|
|
WO2021074389A1
(en)
|
2019-10-16 |
2021-04-22 |
Enterome S.A. |
Immunogenic compounds for treatment of adrenal cancer
|
|
LT4021487T
(lt)
|
2019-11-15 |
2024-02-12 |
Enterome S.A. |
Antigeniniai peptidai, skirti b-ląstelių piktybinių navikų prevencijai ir gydymui
|